JP4515037B2 - Chemical solution injection method and chemical solution injection device - Google Patents

Chemical solution injection method and chemical solution injection device Download PDF

Info

Publication number
JP4515037B2
JP4515037B2 JP2003087748A JP2003087748A JP4515037B2 JP 4515037 B2 JP4515037 B2 JP 4515037B2 JP 2003087748 A JP2003087748 A JP 2003087748A JP 2003087748 A JP2003087748 A JP 2003087748A JP 4515037 B2 JP4515037 B2 JP 4515037B2
Authority
JP
Japan
Prior art keywords
chemical
syringe
state
subject
switching
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2003087748A
Other languages
Japanese (ja)
Other versions
JP2004290455A (en
Inventor
利雄 金高
尚 齋藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nemoto Kyorindo Co Ltd
Original Assignee
Nemoto Kyorindo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nemoto Kyorindo Co Ltd filed Critical Nemoto Kyorindo Co Ltd
Priority to JP2003087748A priority Critical patent/JP4515037B2/en
Publication of JP2004290455A publication Critical patent/JP2004290455A/en
Application granted granted Critical
Publication of JP4515037B2 publication Critical patent/JP4515037B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/145Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M5/1452Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/1407Infusion of two or more substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/007Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests for contrast media

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Description

【0001】
【発明の属する技術分野】
本発明は、被験者に薬液を注入する薬液注入方法および薬液注入装置に関し、特に、薬液として造影剤と生理食塩水を注入する薬液注入方法および薬液注入装置に関する。
【0002】
【従来の技術】
従来、被験者の透視画像である断層画像を撮像する透視撮像装置としては、CT(Computed Tomography)スキャナ、MRI(Magnetic Resonance Imaging)装置、PET(Positron Emission Tomography)装置等があり、被験者の透視画像である血管画像を撮像する医療装置としては、アンギオ装置、MRA(MR Angio)装置等が知られている。
【0003】
この種の装置を使用する際、被験者に造影剤や生理食塩水等の薬液を注入する場合があり、この注入作業を自動的に実行する薬液注入装置も実用化されている。このような薬液注入装置としては、例えば、駆動モータやスライダ機構を有しており、薬液シリンジが着脱自在に装着されるものが開示されている(例えば特許文献1,2参照。)。
【0004】
ところで、PET検査では、造影剤として、ごく微量の放射線を出すポジトロン核種である例えばフルオロデオキシグルコース(FDG)が用いられている。このため、PET検査では、日常生活で1年間に自然界から受ける放射線とほぼ等しい2〜3mSv(ミリシーベルト)程度の放射線を受けることになる。
【0005】
【特許文献1】
特開2002−11096号公報(第2項−第3頁、図11−図14)
【特許文献2】
特開2002−102343号公報(第2頁−第3項、図8)
【0006】
【発明が解決しようとする課題】
上述した従来のPET検査では、医師が、薬液シリンジを手動で操作して、被験者に造影剤を静脈注射している場合が多く、薬液シリンジ内や薬液シリンジに連結されたチューブ内に造影剤が残留してしまう問題がある。
【0007】
このため、医師は、薬液シリンジやチューブの取り扱い時に被験者と同様に被ばくしており、医師の被ばく量を極力抑えることが求められている。
【0008】
また、従来の薬液注入方法では、比較的高価な造影剤の全量が注入されないという不都合もある。
【0009】
そこで、本発明は、第1の薬液が第1の薬液シリンジ内やチューブ内に残留することを確実に防止し、第1の薬液の全量を確実に被験者に注入し、医師の放射線被ばくを抑えることができる薬液注入方法および薬液注入装置を提供することを目的とする。
【0010】
【課題を解決するための手段】
上述した目的を達成するため、本発明に係る薬液注入装置は、第1の薬液が充填される第1の薬液シリンジと、第2の薬液が充填される第2の薬液シリンジと、第1および第2の薬液を被験者に注入するためのチューブと、このチューブを介して、第1の薬液シリンジを被験者側に連通させる第1の状態、第2の薬液シリンジを被験者側に連通させる第2の状態、第1の薬液シリンジと第2の薬液シリンジを連通させる第3の状態にそれぞれ切り換えるための切換手段と、この切換手段を第1の状態に切り換えて第1の薬液シリンジ内の薬液を被験者に注入する第1の動作、切換手段を第3の状態に切り換えて第2の薬液シリンジから第1の薬液シリンジに第2の薬液を移送する第2の動作、切換手段を第1の状態に切り換えて第1の薬液シリンジ内の薬液を被験者に注入する第3の動作、切換手段を第2の状態に切り換えて第2の薬液シリンジ内の薬液を被験者に注入する第4の動作をこの順序で有するモードで薬液の注入動作を制御する制御手段とを備える
【0011】
上述した本発明に係る薬液注入装置によれば、第2の動作で、第1の薬液シリンジ内に第2の薬液が移送されることで、第1の薬液シリンジ内に残留した第1の薬液が第2の薬液に混入されて、その後の第3の動作で被験者に注入される。そして、第3の動作で、第2の薬液シリンジから第2の薬液が被験者に注入されることで、チューブ内に残留した第1の薬液が被験者に注入される。したがって、本発明の薬液注入装置によれば、第1の薬液シリンジ内およびチューブ内に第1の薬液を残留させることなく、第1の薬液シリンジ内に充填された第1の薬液の全量が被験者に注入される。
【0012】
また、本発明に係る薬液注入装置では、制御手段は、上述したモードと、第1の動作後に第4の動作を行う他のモードとを選択的に制御してもよい。
【0014】
また、本発明に係る撮像装置は、上述した本発明の薬液注入装置を備え、被験者の透視画像を撮像する。
【0015】
【発明の実施の形態】
以下、本発明の具体的な実施形態について、図面を参照して説明する。
【0016】
本実施形態の薬液注入装置は、PET(Positron Emission Tomography)検査を行う際に、被験者に造影剤および生理食塩水をそれぞれ注入するために用いられる。造影剤としては、フルオロデオキシグルコース(FDG)が用いられている。
【0017】
図1および図2に示すように、薬液注入装置1は、造影剤を注入するための第1のヘッド部6と、生理食塩水を注入するための第2のヘッド部7と、第1および第2のヘッド部6,7から被験者に造影剤および生理食塩水を注入する各輸液路を構成する輸液部8とを備えている。
【0018】
また、この薬液注入装置1は、図3に示すように、第1および第2のヘッド部6,7を制御する制御回路部9と、各種操作を行うための操作部10とを備えている。
【0019】
第1のヘッド部6は、図1および図3に示すように、造影剤が充填される第1のシリンジ11と、この第1のシリンジ11を自動操作するための第1の操作機構13と、第1のシリンジ11を保持するためのシリンジホルダ15とを有している。
【0020】
第1の操作機構13は、第1のシリンジ11のピストン11aを駆動する駆動軸16aと、この駆動軸16aを回転駆動するモータ17aと、このモータ17aの回転を符号化するエンコーダ18aとを有している。駆動軸16aは、ピストン11aの移動方向と平行に設けられており、ピストン11aを押圧する押圧板19aが係合されている。
【0021】
シリンジホルダ15は、図4および図5に示すように、例えばタングステン等によって略円筒状に形成されており、内周部に第1のシリンジ11が保持されている。シリンジホルダ15の外周部には、把持するための取っ手15aが一体に設けられている。
【0022】
また、シリンジホルダ15には、第1のシリンジ11の前端側および後端側をそれぞれ覆う前カバー部材26および後カバー部材27が着脱自在に取り付けられている。これら前カバー部材26および後カバー部材27は、例えばタングステン等によって有底筒状に形成されており、第1のシリンジ11内に充填された造影剤からの放射線を遮断する。また、第1のヘッド部6には、シリンジホルダ15が着脱自在に装着されるホルダ装着部20が設けられている。
【0023】
したがって、医師等は、造影剤が予め充填された第1のシリンジ11が保持されたシリンジホルダ15から前カバー部材26および後カバー部材27をそれぞれ取り外して、シリンジホルダ15をホルダ装着部20に装着することで、第1のシリンジ11が三方活栓21に接続される。このため、医師等は、第1のシリンジ11内の造影剤にさらされることが僅かになるため、造影剤による被ばくが抑えられる。なお、必要に応じて、シリンジホルダ15の取っ手15aを把持して、第1のシリンジ11を手動で操作することによって、造影剤を被験者に注入することも可能である。
【0024】
第2のヘッド部7は、生理食塩水が充填される第2のシリンジ12と、この第2のシリンジ12を自動操作するための第2の操作機構14とを有している。第2の操作機構14は、第2のシリンジ12のピストン12aを駆動する駆動軸16bと、この駆動軸16bを回転駆動するモータ17bと、このモータ17bの回転を符号化するエンコーダ18bとを有している。駆動軸16bは、ピストン12aの移動方向と平行に設けられており、ピストン12aを押圧する押圧板19bが係合されている。
【0025】
輸液部8は、図1および図3に示すように、輸液路を切り換えるための三方活栓21と、この三方活栓21を介して造影剤および生理食塩水を被験者に注入するための輸液チューブ22と、第2のシリンジ12を三方活栓21に連結するための連結チューブ23と、三方活栓21の状態を切り換えるための活栓切換機構24とを有している。
【0026】
三方活栓21には、第1のシリンジ11が連結されており、輸液チューブ22の一端が連結されている。この輸液チューブ22の他端には、注射針25が取り付けられている。また、三方活栓21には、連結チューブ23の一端が連結されており、この連結チューブ23の他端が第2のシリンジ12に連結されている。
【0027】
そして、この三方活栓21は、輸液チューブ22を介して第1のシリンジ11を被験者側に連通させる第1の状態と、輸液チューブ22および連結チューブ23を介して第2のシリンジ12を被験者側に連通させる第2の状態と、連結チューブ23を介して第1のシリンジ11と第2のシリンジ12を連通させる第3の状態とにそれぞれ切り換えられる。
【0028】
活栓切換機構24は、制御回路部9に電気的に接続されており、制御回路部9からの制御信号に基づいて三方活栓21を上述した第1の状態、第2の状態、第3の状態とにそれぞれ切り換える。
【0029】
制御回路部9は、図示しないが、第1および第2のヘッド部6,7の各モータ17a,17bを回転駆動する駆動回路や各エンコーダ18a,18bからの信号を検出する検出回路等を有している。また、制御回路部9は、図3に示すように、外部電力が供給される電源回路28に電気的に接続されている。そして、この制御回路部9は、後述する各AモードおよびBモードに応じて、活栓切換機構24をそれぞれ駆動制御する。
【0030】
操作部10は、各種操作を行うための複数の操作釦10aと、各種状態を表示する複数の表示板10bとを有している。表示板10bには、後述するが、選択されているAモードまたはBモードを示す表示や、第2のシリンジ12内に充填された生理食塩水の設定量等が表示される。
【0031】
以上のように構成された薬液注入装置1について、造影剤および生理食塩水を注入する動作を説明する。
【0032】
まず、設定量の造影剤が予め充填された第1のシリンジ11が保持されたシリンジホルダ15をホルダ装着部20内に装着する。続いて、三方活栓21を第2の状態に切り換えて、第2のシリンジ12によって微量の生理食塩水を打ち出し、輸液チューブ22および連結チューブ23内の空気抜きを行う。この後、第2のヘッド部7は、第2の操作機構14によって第2のシリンジ12のピストン12aに押圧板19bが当接されて、待機状態となる。
【0033】
そして、薬液注入装置1は、AモードとBモードとに選択的に切り換えられて使用される。Aモードによる注入動作を行う場合について、図面を参照して説明する。
【0034】
図6および図7(a)に示すように、ステップ31から開始し、制御回路部9からの制御信号に基づいて、活栓切換機構24が三方活栓21を第1の状態に切り換えて、第1のシリンジ11から被験者に造影剤を注入する(ステップ32)。
【0035】
続いて、図6および図7(b)に示すように、制御回路部9からの制御信号に基づいて、活栓切換機構24が三方活栓21を第2の状態に切り換えて、第2のシリンジ12から被験者に設定量の生理食塩水を注入し(ステップ33)、ステップ34でAモードによる注入動作が終了する。
【0036】
なお、制御回路部9は、上述した待機時に、第2のシリンジ12のピストン12bに当接された押圧板19bの位置によって、第2のシリンジ12内に充填されている生理食塩水の量を検出する。制御回路部9は、第2のシリンジ12内に設定量以上の生理食塩水が充填されていない場合には、注入動作が不能になるように駆動制御を行う。
【0037】
つぎに、Bモードによる注入動作を行う場合について図面を参照して説明する。
【0038】
図8および図9(a)に示すように、ステップ41から開始し、制御回路部9からの制御信号に基づいて、活栓切換機構24が三方活栓21を第1の状態に切り換えて、第1のシリンジ11から輸液チューブ22を介して被験者に造影剤を注入する(ステップ42)。
【0039】
図9(b)に示すように、制御回路部9からの制御信号に基づいて、活栓切換機構24が三方活栓21を第3の状態に切り換えて、第1のシリンジ11のピストン11aを所定量、例えば5mL程度だけ後退させる(ステップ43)。続いて、図9(c)に示すように、三方活栓21が第3の状態で、第2のシリンジ12から第1のシリンジ11内に所定量、例えば5mL程度の生理食塩水を移送する(ステップ44)。これによって、第1のシリンジ11内に残留した造影剤が生理食塩水に良好に混入される。
【0040】
図9(d)に示すように、制御回路部9からの制御信号に基づいて、活栓切換機構24が三方活栓21を第1の状態に切り換えて、第1のシリンジ11に移送された生理食塩水を、第1のシリンジ内に残留していた造影剤とともに被験者に注入する(ステップ45)。
【0041】
最後に、図9(e)に示すように、制御回路部9からの制御信号に基づいて、活栓切換機構24が三方活栓21を第の状態に切り換えて、第2のシリンジ12から被験者に設定量の生理食塩水を注入し(ステップ46)、ステップ47でBモードによる注入動作が終了する。したがって、このBモードによれば、第1のシリンジ11内に残留した造影剤および輸液チューブ22内に残留した造影剤を被験者に注入することができる。
【0042】
なお、制御回路部9は、上述した待機時に、第2のシリンジ12のピストン12bに当接された押圧板19bの位置によって、第2のシリンジ12内に充填されている生理食塩水の量を検出する。制御回路部9は、第2のシリンジ12内に例えば(設定量+5mL)以上の生理食塩水が充填されていない場合には、注入動作が不能になるように駆動制御を行う。
【0043】
上述したように、薬液注入装置1は、第1のシリンジ11を被験者側に連通させる第1の状態、第2のシリンジ12を被験者側に連通させる第2の状態、第1のシリンジ11と第2のシリンジ12を連通させる第3の状態に三方活栓21をそれぞれ切り換える活栓切換機構24と、この活栓切換機構24を第1の状態、第3の状態、第1の状態、第2の状態の順序で切り換えるBモードで駆動制御する制御回路部9とを備えることによって、第1のシリンジ11内に充填された造影剤の全量を被験者に確実に注入することができる。
【0044】
また、この薬液注入装置1によれば、制御回路部9による自動制御によって、造影剤および生理食塩水を注入する一連の動作を確実に行われるため、輸液チューブ22内に残留した造影剤等によって医師が放射線被ばくを受けることが抑えられる。
【0045】
なお、上述した輸液部8は、三方活栓21によって各輸液路が切り換えられるように構成にされたが、例えば各輸液路がそれぞれ独立して開閉されるように構成されてもよい。
【0046】
図10に示すように、他の輸液部50は、第1のシリンジ11および第2のシリンジ12にそれぞれ連結された注入チューブ51,52と、造影剤および生理食塩水を被験者に注入するための輸液チューブ53と、これら各チューブ51,52,53を連結する連結部材54と、各チューブ51,52,53の輸液路を独立して開閉する輸液路開閉機構56とを有している。
【0047】
各チューブ51,52,53は、例えば金属メッシュが設けられた耐圧チューブが用いられている。
【0048】
各輸液路開閉機構56は、各チューブ51,52,53に対応する位置に配設されており、図11および図12に示すように、各チューブ51,52,53を挟み込むための一組の挟持部材61,62と、一方の挟持部材61に対して他方の挟持部材62を移動するための移動機構63と、これら挟持部材61,62および移動機構63を支持する支持部材64とを有している。
【0049】
挟持部材61は、支持部材64の支持片64aに固定されている。挟持部材62は、支持部材64の支持片64bに設けられたガイド穴内に移動可能に案内されている。そして、挟持部材61,62間には、各チューブ51,52,53が挿通されて設けられている。
【0050】
移動機構63は、挟持部材62を移動させるカム66と、このカム66を回転可能に支持する回転軸67と、カム66を回転駆動するギア68と、このギア68を回転駆動するモータ69とを有している。
【0051】
カム66は、挟持部材62の下端に対向する位置に設けられている。回転軸67は、支持部材64に回転自在に支持されており、一端側にカム66が固定されている。ギア68は、回転軸67の他端側に固定されている。モータ69は、支持部材64に固定されており、ギア68を回転駆動するピニオンギア(不図示)を有している。また、モータ69は、制御回路部9に電気的に接続されており、制御回路部9からの制御信号に基づいて回転駆動される。
【0052】
以上のように構成された輸液路開閉機構56は、制御回路部9によってモータ69が回転駆動されることで、ギア68を介してカム66が回転駆動される。カム66が回転駆動されることによって挟持部材62が上方に移動されて、各挟持部材61,62間に各チューブ51,52,53が挟み込まれて押し潰されるため、輸液路が閉塞される。また、同様に、輸液路開閉機構56は、カム66が回転されることで、挟持部材62が自重で下方に移動されて、輸液路を開放する。
【0053】
また、上述した輸液路開閉機構56は、各チューブ51,52,53を押し潰して輸液路を開閉する構成にされたが、例えば電磁弁等によって各輸液路を開閉する構成が適用されてもよい。
【0054】
最後に、上述した薬液注入装置1が適用される透視画像装置について、簡単に説明する。図13に示すように、PET装置である透視画像装置2は、上述した薬液注入装置1と、造影剤が注入された被験者を撮影するための撮像ユニット3と、この撮像ユニット3を制御する制御ユニット4とを備えて構成されている。薬液注入装置1は、撮像ユニット3の検査台の近傍に配置され、検査台上に横になった被験者に対して造影剤および生理食塩水の注入が行われる。
【0055】
なお、本発明に係る薬液注入装置は、PET装置に適用されたが、CT(Computed Tomography)スキャナ、MRI(Magnetic Resonance Imaging)装置等の他の透視画像装置に用いられてもよいことは勿論である。
【0056】
【発明の効果】
上述したように本発明に係る薬液注入装置によれば、切換手段が第1の状態で第1の薬液シリンジの薬液を被験者に注入する第1の動作と、切換手段が第3の状態で第2の薬液シリンジから第1の薬液シリンジに第2の薬液を移送する第2の動作と、切換手段が第1の状態で第1の薬液シリンジの薬液を被験者に注入する第3の動作と、切換手段が第2の状態で第2の薬液シリンジの薬液を被験者に注入する第4の動作とを有するモードで薬液の注入動作を行うことによって、第1の薬液シリンジ内に充填された造影剤を第1の薬液シリンジ内やチューブ内に残留させることなく、第1の薬液の全量を被験者に確実に注入することができる。
【図面の簡単な説明】
【図1】本発明に係る薬液注入装置を示す斜視図である。
【図2】前記薬液注入装置からシリンジホルダが取り外された状態を示す斜視図である。
【図3】前記薬液注入装置を示す模式図である。
【図4】前記シリンジホルダに前カバー部材および後カバー部材が取り付けられた状態を示す斜視図である。
【図5】前記シリンジホルダから前カバー部材および後カバー部材が取り外された状態を示す斜視図である。
【図6】Aモードを示すフローチャートである。
【図7】前記Aモードにおける第1および第2のシリンジの動作を示す模式図である。
【図8】Bモードを示すフローチャートである。
【図9】前記Bモードにおける第1および第2のシリンジの動作を示す模式図である。
【図10】他の輸液部を示す模式図である。
【図11】輸液開閉機構を示す斜視図である。
【図12】輸液開閉機構を示す模式図である。
【図13】本発明に係る撮像装置を示す斜視図である。
【符号の説明】
1 薬液注入装置
6 第1のヘッド部
7 第2のヘッド部
8 輸液部
9 制御回路部
10 操作部
11 第1のシリンジ
12 第2のシリンジ
13 第1の操作機構
14 第2の操作機構
15 シリンジホルダ
20 ホルダ装着部
21 三方活栓
22 輸液チューブ
23 連結チューブ
24 活栓切換機構
28 電源回路部
[0001]
BACKGROUND OF THE INVENTION
The present invention relates to a chemical solution injection method and a chemical solution injection device for injecting a chemical solution into a subject, and particularly to a chemical solution injection method and a chemical solution injection device for injecting a contrast medium and physiological saline as a chemical solution.
[0002]
[Prior art]
Conventionally, as a fluoroscopic imaging apparatus that captures a tomographic image that is a fluoroscopic image of a subject, there are a CT (Computed Tomography) scanner, an MRI (Magnetic Resonance Imaging) apparatus, a PET (Positron Emission Tomography) apparatus, and the like. As medical devices for capturing a blood vessel image, an angio device, an MRA (MR Angio) device, and the like are known.
[0003]
When using this type of device, a chemical solution such as a contrast medium or physiological saline may be injected into a subject, and a chemical solution injection device that automatically executes this injection operation has been put into practical use. As such a chemical solution injection device, for example, a device having a drive motor and a slider mechanism to which a chemical solution syringe is detachably mounted is disclosed (for example, see Patent Documents 1 and 2).
[0004]
By the way, in PET examination, for example, fluorodeoxyglucose (FDG), which is a positron nuclide that emits a very small amount of radiation, is used as a contrast agent. For this reason, in the PET examination, radiation of about 2 to 3 mSv (milli-sievert) equivalent to radiation received from the natural world in one year in daily life is received.
[0005]
[Patent Document 1]
Japanese Unexamined Patent Publication No. 2002-11096 (2nd to 3rd pages, FIGS. 11 to 14)
[Patent Document 2]
JP 2002-102343 A (2nd page-3rd item, FIG. 8)
[0006]
[Problems to be solved by the invention]
In the above-described conventional PET examination, a doctor often manually operates a drug solution syringe and intravenously injects a contrast medium into a subject, and the contrast medium is contained in the drug solution syringe or a tube connected to the drug solution syringe. There is a problem that it remains.
[0007]
For this reason, doctors are exposed in the same manner as the subject when handling chemical syringes and tubes, and it is required to minimize the amount of exposure by doctors.
[0008]
In addition, the conventional chemical solution injection method has a disadvantage that the entire amount of the relatively expensive contrast agent is not injected.
[0009]
Therefore, the present invention reliably prevents the first chemical solution from remaining in the first chemical solution syringe or the tube, reliably injects the entire amount of the first chemical solution into the subject, and suppresses the radiation exposure of the doctor. It is an object of the present invention to provide a chemical solution injection method and a chemical solution injection device that can perform the same.
[0010]
[Means for Solving the Problems]
In order to achieve the above-described object, a chemical liquid injection device according to the present invention includes a first chemical liquid syringe filled with a first chemical liquid, a second chemical liquid syringe filled with a second chemical liquid, A tube for injecting the second drug solution into the subject, a first state in which the first drug solution syringe is communicated to the subject side through the tube, and a second state in which the second drug solution syringe is communicated to the subject side A switching means for switching to a third state in which the first chemical liquid syringe and the second chemical liquid syringe are communicated with each other, and switching the switching means to the first state to transfer the chemical liquid in the first chemical liquid syringe to the subject. The first operation for injecting the liquid into the first state, the switching means to the third state, the second operation for transferring the second chemical liquid from the second chemical liquid syringe to the first chemical liquid syringe, and the switching means to the first state Switch to the first chemical solution In the mode having the third operation for injecting the chemical liquid in the range into the subject, and the fourth operation for switching the switching means to the second state and injecting the chemical liquid in the second chemical syringe to the subject in this order. Control means for controlling the injection operation .
[0011]
According to the liquid injector according to the present invention described above, in the second operation, that the second chemical liquid is transferred to the first chemical solution in the syringe, the first chemical liquid remaining in the first chemical solution in the syringe Is mixed into the second chemical solution and then injected into the subject in a third action . Then, in the third operation, the second chemical liquid is injected from the second chemical liquid syringe into the subject, whereby the first chemical liquid remaining in the tube is injected into the subject. Therefore, according to the liquid injector of the present invention, without leaving the first chemical solution to the first chemical solution in the syringe and the tube, the total amount of the first chemical solution filled in the first chemical solution in the syringe is subject Injected into.
[0012]
Moreover, in the chemical injection device according to the present invention, the control unit may selectively control the above-described mode and another mode in which the fourth operation is performed after the first operation.
[0014]
Moreover, the imaging device according to the present invention includes the above-described chemical liquid injector of the present invention and captures a fluoroscopic image of a subject.
[0015]
DETAILED DESCRIPTION OF THE INVENTION
Hereinafter, specific embodiments of the present invention will be described with reference to the drawings.
[0016]
The chemical injection device of the present embodiment is used to inject a contrast medium and physiological saline into a subject when performing a PET (Positron Emission Tomography) examination. As a contrast agent, fluorodeoxyglucose (FDG) is used.
[0017]
As shown in FIG. 1 and FIG. 2, the chemical liquid injector 1 includes a first head 6 for injecting a contrast agent, a second head 7 for injecting physiological saline, And an infusion part 8 constituting each infusion path for injecting a contrast medium and physiological saline into the subject from the second head parts 6 and 7.
[0018]
Further, as shown in FIG. 3, the chemical injection device 1 includes a control circuit unit 9 that controls the first and second head units 6 and 7, and an operation unit 10 for performing various operations. .
[0019]
As shown in FIGS. 1 and 3, the first head unit 6 includes a first syringe 11 filled with a contrast agent, and a first operation mechanism 13 for automatically operating the first syringe 11. And a syringe holder 15 for holding the first syringe 11.
[0020]
The first operating mechanism 13 includes a drive shaft 16a that drives the piston 11a of the first syringe 11, a motor 17a that rotationally drives the drive shaft 16a, and an encoder 18a that encodes the rotation of the motor 17a. is doing. The drive shaft 16a is provided in parallel with the moving direction of the piston 11a, and a pressing plate 19a that presses the piston 11a is engaged therewith.
[0021]
As shown in FIGS. 4 and 5, the syringe holder 15 is formed in a substantially cylindrical shape with tungsten or the like, for example, and the first syringe 11 is held on the inner peripheral portion. A handle 15 a for gripping is integrally provided on the outer peripheral portion of the syringe holder 15.
[0022]
A front cover member 26 and a rear cover member 27 that cover the front end side and the rear end side of the first syringe 11 are detachably attached to the syringe holder 15. The front cover member 26 and the rear cover member 27 are formed in a bottomed cylindrical shape with tungsten or the like, for example, and block radiation from the contrast agent filled in the first syringe 11. In addition, the first head portion 6 is provided with a holder mounting portion 20 to which the syringe holder 15 is detachably mounted.
[0023]
Therefore, the doctor or the like removes the front cover member 26 and the rear cover member 27 from the syringe holder 15 holding the first syringe 11 preliminarily filled with the contrast agent, and attaches the syringe holder 15 to the holder mounting portion 20. As a result, the first syringe 11 is connected to the three-way cock 21. For this reason, since a doctor etc. are hardly exposed to the contrast agent in the 1st syringe 11, exposure by a contrast agent is suppressed. In addition, as needed, it is also possible to inject a contrast medium into a subject by gripping the handle 15a of the syringe holder 15 and manually operating the first syringe 11.
[0024]
The second head unit 7 includes a second syringe 12 filled with physiological saline and a second operation mechanism 14 for automatically operating the second syringe 12. The second operation mechanism 14 includes a drive shaft 16b that drives the piston 12a of the second syringe 12, a motor 17b that rotationally drives the drive shaft 16b, and an encoder 18b that encodes the rotation of the motor 17b. is doing. The drive shaft 16b is provided in parallel with the moving direction of the piston 12a, and a pressing plate 19b that presses the piston 12a is engaged therewith.
[0025]
As shown in FIGS. 1 and 3, the infusion part 8 includes a three-way cock 21 for switching the infusion path, and an infusion tube 22 for injecting a contrast medium and physiological saline into the subject via the three-way cock 21. The connecting tube 23 for connecting the second syringe 12 to the three-way stopcock 21 and the stopcock switching mechanism 24 for switching the state of the three-way stopcock 21 are provided.
[0026]
The three-way cock 21 is connected to the first syringe 11, and one end of the infusion tube 22 is connected to the three-way cock 21. An injection needle 25 is attached to the other end of the infusion tube 22 . In addition, one end of a connection tube 23 is connected to the three-way cock 21, and the other end of the connection tube 23 is connected to the second syringe 12.
[0027]
The three-way stopcock 21 has a first state in which the first syringe 11 communicates with the subject via the infusion tube 22, and a second syringe 12 on the subject side via the infusion tube 22 and the connecting tube 23. There are respectively switched to a second state in which the first syringe 11 and the second syringe 12 are communicated with each other through a connecting tube 23 .
[0028]
The stopcock switching mechanism 24 is electrically connected to the control circuit unit 9, and based on the control signal from the control circuit unit 9, the three-way stopcock 21 is in the first state, the second state, and the third state described above. Switch to and respectively.
[0029]
Although not shown, the control circuit unit 9 includes a drive circuit that rotates and drives the motors 17a and 17b of the first and second head units 6 and 7, a detection circuit that detects signals from the encoders 18a and 18b, and the like. is doing. Further, as shown in FIG. 3, the control circuit unit 9 is electrically connected to a power supply circuit 28 to which external power is supplied. The control circuit unit 9 drives and controls the stopcock switching mechanism 24 in accordance with each A mode and B mode described later.
[0030]
The operation unit 10 includes a plurality of operation buttons 10a for performing various operations and a plurality of display boards 10b for displaying various states. As will be described later, a display indicating the selected A mode or B mode, a set amount of physiological saline filled in the second syringe 12, and the like are displayed on the display board 10b.
[0031]
About the chemical | medical solution injection device 1 comprised as mentioned above, the operation | movement which inject | pours a contrast agent and physiological saline is demonstrated.
[0032]
First, the syringe holder 15 holding the first syringe 11 preliminarily filled with a set amount of contrast agent is mounted in the holder mounting portion 20. Subsequently, the three-way stopcock 21 is switched to the second state, a trace amount of physiological saline is ejected by the second syringe 12, and the air in the infusion tube 22 and the connecting tube 23 is vented. Thereafter, the second head unit 7 is in a standby state by the pressing plate 19b being brought into contact with the piston 12a of the second syringe 12 by the second operation mechanism 14.
[0033]
And the chemical injection device 1 is selectively used between the A mode and the B mode. The case of performing the injection operation in the A mode will be described with reference to the drawings.
[0034]
As shown in FIG. 6 and FIG. 7A, starting from step 31, the stopcock switching mechanism 24 switches the three-way stopcock 21 to the first state based on the control signal from the control circuit unit 9, and the first The contrast medium is injected from the syringe 11 into the subject (step 32).
[0035]
Subsequently, as shown in FIGS. 6 and 7B, the stopcock switching mechanism 24 switches the three-way stopcock 21 to the second state based on the control signal from the control circuit unit 9, and the second syringe 12. Then, a set amount of physiological saline is injected into the subject (step 33), and in step 34, the injection operation in the A mode is completed.
[0036]
In addition, the control circuit unit 9 determines the amount of the physiological saline filled in the second syringe 12 according to the position of the pressing plate 19b in contact with the piston 12b of the second syringe 12 during the above-described standby. To detect. The control circuit unit 9 performs drive control so that the injection operation is disabled when the second syringe 12 is not filled with a physiological saline of a set amount or more.
[0037]
Next, the case of performing the injection operation in the B mode will be described with reference to the drawings.
[0038]
As shown in FIGS. 8 and 9A, starting from step 41, based on the control signal from the control circuit unit 9, the stopcock switching mechanism 24 switches the three-way stopcock 21 to the first state, A contrast medium is injected from the syringe 11 into the subject through the infusion tube 22 (step 42).
[0039]
As shown in FIG. 9B, based on a control signal from the control circuit unit 9, the stopcock switching mechanism 24 switches the three-way stopcock 21 to the third state, and the piston 11a of the first syringe 11 is set to a predetermined amount. For example, about 5 mL is retracted (step 43). Subsequently, as shown in FIG. 9C, a predetermined amount, for example, about 5 mL of physiological saline is transferred from the second syringe 12 into the first syringe 11 with the three-way cock 21 in the third state ( Step 44). As a result, the contrast agent remaining in the first syringe 11 is well mixed into the physiological saline.
[0040]
As shown in FIG. 9 (d), the stopcock switching mechanism 24 switches the three-way stopcock 21 to the first state on the basis of the control signal from the control circuit unit 9, and the physiological saline transferred to the first syringe 11. Water is injected into the subject along with the contrast agent remaining in the first syringe (step 45).
[0041]
Finally, as shown in FIG. 9 (e), the stopcock switching mechanism 24 switches the three-way stopcock 21 to the second state based on the control signal from the control circuit unit 9, and the second syringe 12 sends the test subject to the subject. A set amount of physiological saline is injected (step 46), and in step 47, the injection operation in the B mode ends. Therefore, according to this B mode, the contrast agent remaining in the first syringe 11 and the contrast agent remaining in the infusion tube 22 can be injected into the subject.
[0042]
In addition, the control circuit unit 9 determines the amount of physiological saline filled in the second syringe 12 according to the position of the pressing plate 19b that is in contact with the piston 12b of the second syringe 12 during the above-described standby. To detect. When the second syringe 12 is not filled with, for example, (set amount + 5 mL) or more of physiological saline, the control circuit unit 9 performs drive control so that the injection operation is disabled.
[0043]
As described above, the chemical injection device 1 includes the first state in which the first syringe 11 communicates with the subject, the second state in which the second syringe 12 communicates with the subject, the first syringe 11 and the first syringe 11. The stopcock switching mechanism 24 for switching the three-way stopcock 21 to the third state where the two syringes 12 are communicated, and the stopcock switching mechanism 24 in the first state, the third state, the first state, and the second state. By including the control circuit unit 9 that performs drive control in the B mode that switches in order, the entire amount of the contrast agent filled in the first syringe 11 can be reliably injected into the subject.
[0044]
Moreover, according to this chemical | medical solution injection device 1, since a series of operation | movement which inject | pours a contrast agent and a physiological saline is reliably performed by the automatic control by the control circuit part 9, it depends on the contrast agent etc. which remain | survived in the infusion tube 22 Doctors are prevented from receiving radiation exposure.
[0045]
In addition, although the infusion part 8 mentioned above was comprised so that each infusion path could be switched by the three-way cock 21, you may be comprised so that each infusion path may be opened and closed independently, for example.
[0046]
As shown in FIG. 10, the other infusion part 50 includes injection tubes 51 and 52 connected to the first syringe 11 and the second syringe 12, respectively, and injects contrast medium and physiological saline into the subject. An infusion tube 53, a connecting member 54 that connects the tubes 51, 52, and 53, and an infusion path opening / closing mechanism 56 that opens and closes the infusion channels of the tubes 51, 52, and 53 independently.
[0047]
As each tube 51, 52, 53, for example, a pressure-resistant tube provided with a metal mesh is used.
[0048]
Each infusion path opening / closing mechanism 56 is disposed at a position corresponding to each tube 51, 52, 53, and as shown in FIGS. 11 and 12, a set of sandwiching each tube 51, 52, 53. The holding members 61 and 62, a moving mechanism 63 for moving the other holding member 62 relative to the one holding member 61, and a support member 64 for supporting the holding members 61 and 62 and the moving mechanism 63. ing.
[0049]
The clamping member 61 is fixed to the support piece 64 a of the support member 64. The clamping member 62 is guided so as to be movable in a guide hole provided in the support piece 64 b of the support member 64. Each tube 51, 52, 53 is inserted between the clamping members 61, 62.
[0050]
The moving mechanism 63 includes a cam 66 that moves the clamping member 62, a rotary shaft 67 that rotatably supports the cam 66, a gear 68 that rotationally drives the cam 66, and a motor 69 that rotationally drives the gear 68. Have.
[0051]
The cam 66 is provided at a position facing the lower end of the clamping member 62. The rotary shaft 67 is rotatably supported by the support member 64, and a cam 66 is fixed to one end side. The gear 68 is fixed to the other end side of the rotating shaft 67. The motor 69 is fixed to the support member 64 and has a pinion gear (not shown) that rotationally drives the gear 68. The motor 69 is electrically connected to the control circuit unit 9 and is driven to rotate based on a control signal from the control circuit unit 9.
[0052]
In the infusion channel opening / closing mechanism 56 configured as described above, the cam 66 is rotationally driven via the gear 68 when the motor 69 is rotationally driven by the control circuit unit 9. When the cam 66 is rotationally driven, the clamping member 62 is moved upward, and the tubes 51, 52, 53 are sandwiched between the clamping members 61, 62 and are crushed, so that the infusion path is closed. Similarly, in the infusion path opening / closing mechanism 56, when the cam 66 is rotated, the clamping member 62 is moved downward by its own weight to open the infusion path.
[0053]
In addition, the above-described infusion path opening / closing mechanism 56 is configured to open and close the infusion path by crushing the tubes 51, 52, and 53. Good.
[0054]
Finally, a fluoroscopic image device to which the above-described chemical liquid injector 1 is applied will be briefly described. As shown in FIG. 13, the fluoroscopic image device 2 which is a PET device includes the above-described chemical liquid injector 1, an imaging unit 3 for imaging a subject into which a contrast agent has been injected, and a control for controlling the imaging unit 3. And a unit 4. The chemical solution injector 1 is disposed in the vicinity of the examination table of the imaging unit 3 and injects a contrast medium and physiological saline to a subject lying on the examination table.
[0055]
The chemical injection device according to the present invention is applied to a PET device, but may be used for other fluoroscopic image devices such as a CT (Computed Tomography) scanner and an MRI (Magnetic Resonance Imaging) device. is there.
[0056]
【The invention's effect】
According to the liquid injector according to the present invention as described above, the first to the operation switching means for injecting a liquid medicine in the first chemical liquid in the syringe in a first state in a subject, switching means in the third state a second operation for transferring the second chemical liquid from the second liquid syringe into a first liquid syringe, the third operation switch means for injecting a liquid medicine in the first chemical solution in the syringe to a subject in a first state And the switching means is filled in the first drug solution syringe by performing the drug solution injection operation in a mode having a fourth operation for injecting the drug solution in the second drug solution syringe to the subject in the second state. The entire amount of the first drug solution can be reliably injected into the subject without leaving the contrast medium remaining in the first drug solution syringe or tube.
[Brief description of the drawings]
FIG. 1 is a perspective view showing a chemical liquid injector according to the present invention.
FIG. 2 is a perspective view showing a state where a syringe holder is removed from the chemical liquid injector.
FIG. 3 is a schematic view showing the chemical liquid injector.
FIG. 4 is a perspective view showing a state where a front cover member and a rear cover member are attached to the syringe holder.
FIG. 5 is a perspective view showing a state where a front cover member and a rear cover member are removed from the syringe holder.
FIG. 6 is a flowchart showing an A mode.
FIG. 7 is a schematic diagram showing the operation of the first and second syringes in the A mode.
FIG. 8 is a flowchart showing a B mode.
FIG. 9 is a schematic diagram showing the operation of the first and second syringes in the B mode.
FIG. 10 is a schematic view showing another infusion part.
FIG. 11 is a perspective view showing an infusion opening / closing mechanism.
FIG. 12 is a schematic view showing an infusion opening / closing mechanism.
FIG. 13 is a perspective view showing an imaging apparatus according to the present invention.
[Explanation of symbols]
DESCRIPTION OF SYMBOLS 1 Chemical injection device 6 1st head part 7 2nd head part 8 Infusion part 9 Control circuit part 10 Operation part 11 1st syringe 12 2nd syringe 13 1st operation mechanism 14 2nd operation mechanism 15 Syringe Holder 20 Holder mounting portion 21 Three-way stopcock 22 Infusion tube 23 Connection tube 24 Stopcock switching mechanism 28 Power supply circuit portion

Claims (10)

第1の薬液が充填される第1の薬液シリンジと、
第2の薬液が充填される第2の薬液シリンジと、
前記第1および第2の薬液を被験者に注入するためのチューブと、
前記チューブを介して、前記第1の薬液シリンジを被験者側に連通させる第1の状態、前記第2の薬液シリンジを被験者側に連通させる第2の状態、前記第1の薬液シリンジと前記第2の薬液シリンジを連通させる第3の状態にそれぞれ切り換えるための切換手段と、
前記切換手段を前記第1の状態に切り換えて前記第1の薬液シリンジ内の薬液を被験者に注入する第1の動作前記切換手段を前記第3の状態に切り換えて前記第2の薬液シリンジから前記第1の薬液シリンジに第2の薬液を移送する第2の動作前記切換手段を前記第1の状態に切り換えて前記第1の薬液シリンジ内の薬液を被験者に注入する第3の動作前記切換手段を前記第2の状態に切り換えて前記第2の薬液シリンジ内の薬液を被験者に注入する第4の動作をこの順序で有するモードで薬液の注入動作を制御する制御手段と
を備える薬液注入装置。
A first chemical syringe filled with the first chemical,
A second chemical syringe filled with the second chemical,
A tube for injecting the first and second chemicals into the subject;
A first state in which the first chemical syringe is communicated with the subject via the tube, a second state in which the second chemical syringe is communicated with the subject, the first chemical syringe and the second Switching means for switching to a third state in which the chemical syringe is communicated,
A first operation of switching the switching means to the first state and injecting a chemical in the first chemical syringe into the subject, and switching the switching means to the third state from the second chemical syringe. A second operation for transferring the second chemical liquid to the first chemical liquid syringe; a third operation for switching the switching means to the first state and injecting the chemical liquid in the first chemical liquid syringe into the subject ; A liquid medicine comprising: a control means for controlling the liquid medicine injection operation in a mode having a fourth action in this order for switching the switching means to the second state and injecting the liquid medicine in the second liquid medicine syringe into the subject. Injection device.
前記制御手段は、前記モードと、前記切換手段を前記第1の状態、前記第2の状態の順序で切り換えて前記第1の動作後に前記第4の動作を行う他のモードとを選択的に制御する請求項に記載の薬液注入装置。The control means selectively selects the mode and another mode in which the switching means is switched in the order of the first state and the second state and the fourth operation is performed after the first operation. The chemical | medical solution injection device of Claim 1 to control. 前記第1の薬液シリンジおよび前記第2の薬液シリンジをそれぞれ自動操作する操作手段を備える請求項またはに記載の薬液注入装置。The chemical solution injection device according to claim 1 or 2 , further comprising operation means for automatically operating each of the first chemical solution syringe and the second chemical solution syringe. 前記切換手段は、三方活栓を有する請求項ないしのいずれか1項に記載の薬液注入装置。The chemical switching device according to any one of claims 1 to 3 , wherein the switching means includes a three-way cock. 前記切換手段は、前記チューブを押圧して輸液路を開閉する輸液路開閉機構を有する請求項ないしのいずれか1項に記載の薬液注入装置。It said switching means, liquid injector according to any one of claims 1 to 3 having an infusion passage opening and closing mechanism for opening and closing the infusion line by pressing the tube. 前記第1の薬液シリンジを保持するホルダ部材と、前記ホルダ部材が着脱自在に装着されるホルダ装着部とを備える請求項ないしのいずれか1項に記載の薬液注入装置。The chemical solution injection device according to any one of claims 1 to 5 , further comprising a holder member that holds the first chemical solution syringe and a holder mounting portion on which the holder member is detachably mounted. 前記ホルダ部材には、前記第1の薬液シリンジを覆うカバー部材が取り付けられる請求項に記載の薬液注入装置。The chemical | medical solution injection apparatus of Claim 6 to which the cover member which covers the said 1st chemical | medical solution syringe is attached to the said holder member. 前記第1の薬液が造影剤、前記第2の薬液が生理食塩水である請求項ないしのいずれか1項に記載の薬液注入装置。The chemical solution injection device according to any one of claims 1 to 7 , wherein the first chemical solution is a contrast medium, and the second chemical solution is a physiological saline. 前記第1の薬液は、ポジトロン核種を含有する請求項に記載の薬液注入装置。The chemical solution injection device according to claim 8 , wherein the first chemical solution contains a positron nuclide. 請求項ないしのいずれか1項に記載の薬液注入装置を備え、被験者の透視画像を撮像する撮像装置。It includes a liquid injector according to any one of claims 1 to 9, an imaging device for capturing a perspective image of the subject.
JP2003087748A 2003-03-27 2003-03-27 Chemical solution injection method and chemical solution injection device Expired - Fee Related JP4515037B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003087748A JP4515037B2 (en) 2003-03-27 2003-03-27 Chemical solution injection method and chemical solution injection device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003087748A JP4515037B2 (en) 2003-03-27 2003-03-27 Chemical solution injection method and chemical solution injection device

Publications (2)

Publication Number Publication Date
JP2004290455A JP2004290455A (en) 2004-10-21
JP4515037B2 true JP4515037B2 (en) 2010-07-28

Family

ID=33402062

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003087748A Expired - Fee Related JP4515037B2 (en) 2003-03-27 2003-03-27 Chemical solution injection method and chemical solution injection device

Country Status (1)

Country Link
JP (1) JP4515037B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210196883A1 (en) * 2018-07-13 2021-07-01 Aptar France Sas Fluid injection device
US20210338925A1 (en) * 2018-07-13 2021-11-04 Aptar France Sas Fluid product injection device

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4654081B2 (en) * 2005-07-08 2011-03-16 アロカ株式会社 Liquid medicine dispensing device and dispensing method
US20100015011A1 (en) 2005-11-25 2010-01-21 Nemoto Kyorindo Co., Ltd. Connection adapter and chemical liquid connecting apparatus
ES2677024T3 (en) 2007-01-01 2018-07-27 Bayer Healthcare Llc Systems for generation, preparation, transport and administration of integrated radiopharmaceutical products
US9056164B2 (en) 2007-01-01 2015-06-16 Bayer Medical Care Inc. Radiopharmaceutical administration methods, fluid delivery systems and components thereof
ES2391719T3 (en) * 2007-11-19 2012-11-29 Mallinckrodt Llc Fluid delivery system with multi-dose fluid source
JP5726070B2 (en) 2008-06-06 2015-05-27 バイエル メディカル ケア インコーポレーテッド Apparatus and method for delivering fluid infusion boluses to patients and handling harmful fluids
WO2011011346A1 (en) 2009-07-24 2011-01-27 Medrad, Inc. Multi-fluid medical injector system and methods of operation
WO2013153812A1 (en) * 2012-04-12 2013-10-17 株式会社根本杏林堂 Agitating injection device
US9125976B2 (en) 2012-06-07 2015-09-08 Bayer Medical Care Inc. Shield adapters
US9233776B2 (en) 2012-06-07 2016-01-12 Bayer Healthcare Llc Molecular imaging vial transport container and fluid injection system interface
US9889288B2 (en) 2012-06-07 2018-02-13 Bayer Healthcare Llc Tubing connectors
US9393441B2 (en) 2012-06-07 2016-07-19 Bayer Healthcare Llc Radiopharmaceutical delivery and tube management system
US9757306B2 (en) 2013-03-13 2017-09-12 Bayer Healthcare Llc Vial container with collar cap
US9327886B2 (en) 2013-03-13 2016-05-03 Bayer Healthcare Llc Vial container with collar cap
JP6510490B2 (en) * 2014-03-17 2019-05-08 株式会社根本杏林堂 Injection device and control device for injection device
JP6873026B2 (en) * 2017-11-30 2021-05-19 株式会社根本杏林堂 Mixing device, mixing tube, chemical injection system and method of mixing chemicals
CN109984772A (en) * 2019-05-20 2019-07-09 广东省人民医院(广东省医学科学院) A kind of left cardiography check device

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04129568A (en) * 1990-09-20 1992-04-30 Nikko Eng Kk Infusion control device
JPH05329209A (en) * 1992-06-03 1993-12-14 Japan Steel Works Ltd:The Positron drug injector and method for operating injector
JPH07194701A (en) * 1993-12-31 1995-08-01 Nissho Corp Liquid chemicals feeding tool
JPH07213606A (en) * 1994-02-02 1995-08-15 Hamamatsu Photonics Kk Radioactive chemical injecting device
JP2001104492A (en) * 1999-10-05 2001-04-17 Nemoto Kyorindo:Kk Contrast medium-injecting device
WO2002011791A1 (en) * 2000-07-22 2002-02-14 Kim Yong Nyun Liquid supply apparatus
JP2002210007A (en) * 2001-01-18 2002-07-30 Aloka Co Ltd Syringe pump for radioactive pharmaceutical preparation
JP2002533172A (en) * 1998-12-23 2002-10-08 ヒレケス グイド Contrast injection system
WO2002096487A1 (en) * 2001-05-30 2002-12-05 Acist Medical Systems, Inc. Medical injection system

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04129568A (en) * 1990-09-20 1992-04-30 Nikko Eng Kk Infusion control device
JPH05329209A (en) * 1992-06-03 1993-12-14 Japan Steel Works Ltd:The Positron drug injector and method for operating injector
JPH07194701A (en) * 1993-12-31 1995-08-01 Nissho Corp Liquid chemicals feeding tool
JPH07213606A (en) * 1994-02-02 1995-08-15 Hamamatsu Photonics Kk Radioactive chemical injecting device
JP2002533172A (en) * 1998-12-23 2002-10-08 ヒレケス グイド Contrast injection system
JP2001104492A (en) * 1999-10-05 2001-04-17 Nemoto Kyorindo:Kk Contrast medium-injecting device
WO2002011791A1 (en) * 2000-07-22 2002-02-14 Kim Yong Nyun Liquid supply apparatus
JP2002210007A (en) * 2001-01-18 2002-07-30 Aloka Co Ltd Syringe pump for radioactive pharmaceutical preparation
WO2002096487A1 (en) * 2001-05-30 2002-12-05 Acist Medical Systems, Inc. Medical injection system
JP2004538052A (en) * 2001-05-30 2004-12-24 アシスト メディカル システムズ,インク. Medical infusion system

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210196883A1 (en) * 2018-07-13 2021-07-01 Aptar France Sas Fluid injection device
US20210338925A1 (en) * 2018-07-13 2021-11-04 Aptar France Sas Fluid product injection device

Also Published As

Publication number Publication date
JP2004290455A (en) 2004-10-21

Similar Documents

Publication Publication Date Title
JP4515037B2 (en) Chemical solution injection method and chemical solution injection device
JP2004065736A (en) Liquid medicine injection apparatus
CN1925885B (en) Medical solution injection system
US7331938B2 (en) Medicine liquid injection device where medicine liquid sucked up from medicine liquid tank and injected to subject does not flow back
JP3769539B2 (en) Device for injecting medical preparations under CT or MRT control
JP4934431B2 (en) Chemical injection system
CN107708767A (en) Chemical solution injection device, the control method of chemical solution injection device and computer program
EP1820523A1 (en) Controller unit
WO2016084940A1 (en) Drug solution injection device
WO2005002650A1 (en) Chemical liquid injection system detecting attachment and detachment of chemical liquid syringe to and from chemical liquid injection device
JP4850700B2 (en) Chemical injection system
US20200030524A1 (en) Chemical liquid injector
JP4934430B2 (en) Tube connection device
JPWO2006068171A1 (en) Chemical injection device
JP5586310B2 (en) Chemical injection device
JP4044780B2 (en) Injection head
JP4276410B2 (en) MRI compatible injection device
JP2005034178A (en) Liquid chemical injection system
JP4623943B2 (en) Fluoroscopic imaging system
JP4119224B2 (en) Chemical injection device
CN100536955C (en) Tube connection apparatus
JP5329156B2 (en) Chemical injection device and system provided with the same
JP2004187849A (en) Medical solution feeder
JP2004290454A (en) Chemical injector
JP2004243009A (en) Medical solution injection apparatus

Legal Events

Date Code Title Description
RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20041007

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060309

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081210

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090209

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090902

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100428

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100512

R150 Certificate of patent or registration of utility model

Ref document number: 4515037

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130521

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130521

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20160521

Year of fee payment: 6

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees